# To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers

> **NCT02179970** · PHASE1 · COMPLETED · sponsor: **CCTU- Cancer Theme** · enrollment: 26 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma Metastatic
- Ovarian Serous Adenocarcinoma
- Colorectal Cancer Metastatic

## Interventions

- **DRUG:** Plerixafor

## Key facts

- **NCT ID:** NCT02179970
- **Lead sponsor:** CCTU- Cancer Theme
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-12-14
- **Final completion:** 2018-12-14
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-07-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02179970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02179970, "To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02179970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*